Buy These 3 Dividend Stocks Today and Thank Yourself in 20 Years

Coca-Cola delivered solid operating results, with 2025 case volume up 1% and organic sales up 5%, followed by Q1 2026 case volume growth of 3% and organic sales up 10%, while its 2.6% dividend yield remains attractive. General Mills is still in an investment year, with organic sales down 3%, gross margin down 2 percentage points, and adjusted earnings down 25% through the first nine months of fiscal 2026, though guidance was reaffirmed. Hormel’s organic growth has been improving for over a year and its 5.4% yield plus protein exposure are framed as early turnaround positives, but the overall piece highlights lingering sector headwinds from consumer belt-tightening, GLP-1 effects, and input-cost pressure.

Analysis

This is less a “buy defensives” note than a relative-value read on earnings resilience versus investor fatigue. KO is the cleanest quality-to-duration trade because its mix and pricing power make it a defensive compounder even if consumer volumes soften; the key second-order effect is that resilient staples cash flows can pull capital away from lower-quality packaged food peers, widening valuation dispersion inside the sector. That makes KO more of a balance-sheet ballast than a catalyst-rich upside story.

GIS looks like the classic mid-cycle repair trade where the market is pricing a permanent erosion of demand, while management is still in the middle of a margin reset. The risk is that an “investment year” can quietly become a multi-year share-loss story if private label, snacking, or better-for-you brands continue taking shelf space; the bullish case depends on stabilization in organic sales before leverage to the P&L turns back on. If that inflection does not show within the next 2-3 quarters, the high yield may be more value trap than opportunity.

HRL is the more interesting asymmetric setup because the turnaround appears to be gaining traction before consensus is willing to underwrite it. Protein positioning gives it a structural tailwind that most peers do not have, and that matters if GLP-1 adoption changes consumer baskets toward higher-protein formats; the second-order beneficiary could be suppliers and co-packers tied to protein processing capacity. The philanthropic control element also reduces the odds of a short-sighted capital allocation reset, which can actually be a valuation positive when the market is impatient.

The contrarian read is that the market is likely overstating how permanent the margin pressure is for the group: input cost spikes usually create a lagged, temporary earnings air pocket, but food companies with pricing power and brand equity often recover faster than the stock market expects. The better expression is not a blanket long staples basket, but a barbell between KO quality and HRL turnaround, while being selective on GIS until execution proves the turnaround is real.

Key Decisions for Investors

• Long KO as a low-volatility compounder for a 6-12 month horizon; expect limited multiple expansion but durable cash return if defensives continue to rotate in on recession fears.
• Pair trade: long HRL / short GIS for the next 2-4 quarters to express a view that HRL’s operating inflection is ahead of GIS’s margin reset; stop if GIS re-accelerates organic sales or HRL loses pricing discipline.
• Avoid chasing GIS purely on yield until there is at least one more quarter of stable or improving organic sales; the risk/reward is poor if the market reprices it from turnaround to ex-growth staple.
• For income mandates, consider a staged entry in HRL rather than a full position: initial 50%, add on confirmation of sustained organic growth, because the setup is improving but not yet fully de-risked.
• If using options, prefer medium-dated KO call spreads over outright stock for a modest upside/defensive hedge profile; implied upside is capped, but downside should be limited versus owning lower-quality food names.